Be part of the knowledge.™

CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

2861

LikeLikedUnlike

16-30 of 921

Hi-Lo Phaco: Settings and Details
CME/CE
Hi-Lo Phaco: Settings and Details
- Wendell J. Scott, MD
  Peer
0.25 credits
Using Hi-Lo Phaco With Conventional Surgery and Compression Chop
CME/CE
Using Hi-Lo Phaco With Conventional Surgery and Compression Chop
- Wendell J. Scott, MD
  Peer
0.25 credits
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
CME/CE
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
- Steven Fishbane, MD
  Peer
- Maurizio Gallieni, MD
  Peer
0.25 credits
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
CME/CE
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
- Ellie Kelepouris, MD, FACP, FAHA
  Peer
- Nihar R. Desai, MD, MPH
  Peer
0.25 credits
Introduction to Hi-Lo Phacoemulsification
CME/CE
Introduction to Hi-Lo Phacoemulsification
- Wendell J. Scott, MD
  Peer
0.25 credits
MinuteCE®
The Ambulatory HFrEF Blind Spot: Proactively Reducing CV Mortality Risk Despite Optimized GDMT
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
- Javed Butler, MD
  Peer
- Prof. Dr. Johann Bauersachs
  Peer
0.75 credits 5 episodes
advertisement
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
MinuteCE®
When GDMT Isn’t Enough: Understanding Residual Risk in Patients with HFrEF
- Javed Butler, MD
  Peer
0.75 program credits
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
MinuteCE®
GDMT Is Working Fine, Why Add More Therapies? The Clinical Rationale for Layering Therapies in Patients with HFrEF
0.75 program credits
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
MinuteCE®
Do Not Delay: Timing, Triggers, and Identifying the Right Patient for Additional Therapies in HFrEF
0.75 program credits
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
MinuteCE®
Evidence at a Glance: The Totality of Evidence Impacting Clinical Decision-Making in Patients with HFrEF Without a Recent Worsening Event
- Prof. Dr. Johann Bauersachs
  Peer
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
0.75 program credits
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
MinuteCE®
Safety, Clinical Integration, and the Emerging Fifth Pillar in HF Practice
- Prof. Dr. Johann Bauersachs
  Peer
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
0.75 program credits
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
CME/CE
Targeting B7-H3 in ES-SCLC: Advancing Targeted Therapy Through Evidence-Based Innovation and Multidisciplinary Care
- Taofeek K. Owonikoko, MD, PhD
  Peer
0.25 credits
advertisement
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
CME/CE
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
- Prof. Dr. Johann Bauersachs
  Peer
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
  Peer
0.25 credits
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
CME/CE
Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
- María-Victoria Mateos, MD, PhD
  Peer
0.25 credits
Advancing Heart Failure Treatment With Barostim: An Electrophysiologist’s Real-World Success Story
CME/CE
Advancing Heart Failure Treatment With Barostim: An Electrophysiologist’s Real-World Success Story
- Sumit Verma, MD, FACC
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended